189 related articles for article (PubMed ID: 6752641)
1. Gastric inhibitory polypeptide (GIP) and insulin release in response to oral and intravenous glucose in uremic patients.
Lauritzen JB; Lauritsen KB; Olsen ME; Timmerman I
Metabolism; 1982 Nov; 31(11):1096-9. PubMed ID: 6752641
[TBL] [Abstract][Full Text] [Related]
2. Gastric inhibitory polypeptide and insulin release in response to oral and intravenous glucose in coeliac disease.
Lauritsen KB; Lauritzen JB; Christensen KC
Scand J Gastroenterol; 1982 Mar; 17(2):241-5. PubMed ID: 6753103
[TBL] [Abstract][Full Text] [Related]
3. The response of gastric inhibitory polypeptide (GIP) and insulin to glucose in duodenal ulcer patients.
Lauritsen KB; Moody AJ
Diabetologia; 1978 Mar; 14(3):149-53. PubMed ID: 658630
[TBL] [Abstract][Full Text] [Related]
4. Gastric inhibitory polypeptide and insulin: response to intraduodenal and intravenous glucose infusions in fetal and neonatal pigs.
Kühl C; Hornnes PJ; Jensen SL; Lauritsen KB
Endocrinology; 1980 Nov; 107(5):1446-50. PubMed ID: 7000494
[TBL] [Abstract][Full Text] [Related]
5. The association between plasma GIP and insulin after oral glucose.
Lauritsen KB; Moody AJ
Scand J Gastroenterol; 1980; 15(8):953-7. PubMed ID: 7015475
[TBL] [Abstract][Full Text] [Related]
6. Gastric inhibitory polypeptide (GIP) and insulin release after small-bowel resection in man.
Lauritsen KB; Moody AJ; Christensen KC; Lindkaer Jensen S
Scand J Gastroenterol; 1980; 15(7):833-40. PubMed ID: 7010526
[TBL] [Abstract][Full Text] [Related]
7. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man.
Falko JM; Crockett SE; Cataland S; O'Dorisio TM; Kramer W; Mazzaferri EL
Clin Endocrinol (Oxf); 1980 Dec; 13(6):587-93. PubMed ID: 7014042
[TBL] [Abstract][Full Text] [Related]
8. Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release.
Arnold R; Creutzfeldt W; Ebert R; Becker HD; Börger HW; Schafmayer A
Scand J Gastroenterol; 1978; 13(1):41-7. PubMed ID: 635445
[TBL] [Abstract][Full Text] [Related]
9. Glucose-induced GIP levels in patients with insulinoma.
Tamburrano G; Lala A; Mauceri M; Leonetti F; Andreani D
Horm Metab Res; 1984 Dec; 16 Suppl 1():200-3. PubMed ID: 6099816
[TBL] [Abstract][Full Text] [Related]
10. Effect of synthetic human glucose-dependent insulinotropic polypeptide (hGIP) on the release of insulin in man.
Füessl HS; Yiangou Y; Ghatei MA; Goebel FD; Bloom SR
Eur J Clin Invest; 1990 Oct; 20(5):525-9. PubMed ID: 2124984
[TBL] [Abstract][Full Text] [Related]
11. Gastric inhibitory polypeptide (GIP) response to an oral glucose load in the patients with diabetes mellitus.
Nakanome C; Akai H; Umezu M; Toyota T; Goto Y
Tohoku J Exp Med; 1983 Mar; 139(3):287-92. PubMed ID: 6344327
[TBL] [Abstract][Full Text] [Related]
12. Effect of graded intraduodenal glucose infusions on the release and physiological action of gastric inhibitory polypeptide.
McCullough AJ; Miller LJ; Service FJ; Go VL
J Clin Endocrinol Metab; 1983 Feb; 56(2):234-41. PubMed ID: 6337173
[TBL] [Abstract][Full Text] [Related]
13. Discrepant performance on oral and intravenous glucose tolerance tests: the role of gastric inhibitory polypeptide.
Elahi D; Andersen DK; Tobin JD; Andres R
J Clin Endocrinol Metab; 1981 Jun; 52(6):1199-203. PubMed ID: 7014599
[TBL] [Abstract][Full Text] [Related]
14. The effect of total parenteral nutrition (TPN) on the enteroinsular axis in the rat.
Pederson RA; Innis SM; Buchan AM; Chan CB; Brown JC
Regul Pept; 1985 Mar; 10(2-3):199-206. PubMed ID: 3922014
[TBL] [Abstract][Full Text] [Related]
15. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
[TBL] [Abstract][Full Text] [Related]
16. Gastric inhibitory polypeptide (GIP) release and incretin effect after oral glucose in obesity and after jejunoileal bypass.
Lauritsen KB; Christensen KC; Stokholm KH
Scand J Gastroenterol; 1980; 15(4):489-95. PubMed ID: 7001614
[TBL] [Abstract][Full Text] [Related]
17. Effect of intraduodenal and intravenous triglyceride infusions on plasma gastric inhibitory polypeptide and insulin in fetal and neonatal pigs.
Kühl C; Hornnes PJ; Jensen SL; Lauritsen KB
Diabetologia; 1982 Jul; 23(1):41-4. PubMed ID: 6749583
[TBL] [Abstract][Full Text] [Related]
18. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus.
Elahi D; Andersen DK; Muller DC; Tobin JD; Brown JC; Andres R
Diabetes; 1984 Oct; 33(10):950-7. PubMed ID: 6383904
[TBL] [Abstract][Full Text] [Related]
19. Disparity between glucose-dependent insulinotropic polypeptide and insulin responses in obese man.
Sarson DL; Kopelman PG; Besterman HS; Pilkington TR; Bloom SR
Diabetologia; 1983 Nov; 25(5):386-91. PubMed ID: 6360777
[TBL] [Abstract][Full Text] [Related]
20. Gastric inhibitory polypeptide (GIP) and insulin release in duodenal ulcer patients.
Cataland S; O'Dorisio TM; Crockett SE; Mekhjian HS
J Clin Endocrinol Metab; 1978 Sep; 47(3):615-9. PubMed ID: 400727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
